Mural Oncology Statistics

Total Valuation

Mural Oncology has a market cap or net worth of $31.01 million. The enterprise value is -$40.91 million.

Market Cap	31.01M
Enterprise Value	-40.91M

Important Dates

The last earnings date was Monday, August 4, 2025, before market open.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Mural Oncology has 17.32 million shares outstanding. The number of shares has increased by 2.15% in one year.

Current Share Class	17.32M
Shares Outstanding	17.32M
Shares Change (YoY)	+2.15%
Shares Change (QoQ)	+0.60%
Owned by Insiders (%)	1.69%
Owned by Institutions (%)	24.30%
Float	10.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.53
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.09.

Current Ratio	2.87
Quick Ratio	2.71
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-36.46

Financial Efficiency

Return on equity (ROE) is -111.75% and return on invested capital (ROIC) is -60.66%.

Return on Equity (ROE)	-111.75%
Return on Assets (ROA)	-52.60%
Return on Invested Capital (ROIC)	-60.66%
Return on Capital Employed (ROCE)	-229.45%
Revenue Per Employee	n/a
Profits Per Employee	-$1.27M
Employee Count	116
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.99% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-42.99%
50-Day Moving Average	2.36
200-Day Moving Average	3.01
Relative Strength Index (RSI)	33.66
Average Volume (20 Days)	276,179

Short Selling Information

The latest short interest is 253,648, so 1.46% of the outstanding shares have been sold short.

Short Interest	253,648
Short Previous Month	232,683
Short % of Shares Out	1.46%
Short % of Float	2.50%
Short Ratio (days to cover)	3.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-135.69M
Pretax Income	n/a
Net Income	-147.15M
EBITDA	-131.93M
EBIT	-135.69M
Earnings Per Share (EPS)	-$8.59

Full Income Statement

Balance Sheet

The company has $77.09 million in cash and $5.17 million in debt, giving a net cash position of $71.92 million or $4.15 per share.

Cash & Cash Equivalents	77.09M
Total Debt	5.17M
Net Cash	71.92M
Net Cash Per Share	$4.15
Equity (Book Value)	58.78M
Book Value Per Share	3.40
Working Capital	53.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$130.01 million and capital expenditures -$52,000, giving a free cash flow of -$130.06 million.

Operating Cash Flow	-130.01M
Capital Expenditures	-52,000
Free Cash Flow	-130.06M
FCF Per Share	-$7.51

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mural Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.15%
Shareholder Yield	-2.15%
Earnings Yield	-474.52%
FCF Yield	-419.41%

Analyst Forecast

The average price target for Mural Oncology is $12.00, which is 570.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	570.39%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1